IN BRIEF: Genedrive included in Public Health England framework
IN BRIEF: Genedrive included in Public Health England framework
Read moreFri, 01st May 2020 16:17
IN BRIEF: Genedrive included in Public Health England framework
Read more(Sharecast News) - Molecular diagnostics company Genedrive has been successful with its tender to Public Health England (PHE) under Lot 1 of the National Microbiology Framework for diagnostic goods and services, it announced on Monday.
Read moreYourgene wins national contract award for Covid-19 testing services
Read moreAIM WINNERS & LOSERS: Pantheon falls after Alaska drilling results
Read moreTRADING UPDATES: Safestyle in strong start to 2021; Tandem ups payout
Read moreAIM WINNERS & LOSERS: Tandem rises on strong results, positive outlook
Read moreUK earnings, trading statements calendar - next 7 days
Read moreIN BRIEF: Genedrive to distribute pathogen detection assays in US
Read moreTRADING UPDATES: Team PLC prices IPO; Nostra's Cypress doubles
Read moreAIM WINNERS & LOSERS: Blockchain Stocks Rise As Bitcoin Hits New High
Read moreGenedrive Makes First Shipments Of SARS-CoV-2 Test Kits To US
Read moreIN BRIEF: Genedrive Soars After Sealing PCR Test Distribution Deal
Read moreAIM WINNERS & LOSERS: Eurasia Rallies As It Explains Churakov Sale
Read moreUK TRADING UPDATE SUMMARY: Novacyt Tests Can Spot New Virus Strain
Read more(Sharecast News) - Molecular diagnostics company Genedrive has notified the United States Food and Drug Association (FDA) of its intention to import and distribute its 'Genedrive 96 SARS-CoV-2 Kit' prior to an emergency use authorisation (EUA) determination, it announced on Wednesday.
Read more